查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1860102

脑血管血管造影术市场按设备类型、操作模式、应用和最终用户划分 - 全球预测 2025-2032 年

Cerebral Angiography Market by Equipment Type, Operation Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，脑血管造影术市场规模将达到 26.1 亿美元，复合年增长率为 7.05%。

主要市场统计数据
基准年 2024 15.1亿美元
预计年份：2025年 16.2亿美元
预测年份：2032年 26.1亿美元
复合年增长率 (%) 7.05%

对脑血管造影术的目的和临床意义，以及影像学和介入治疗在现代神经血管医学中的整合进行权威说明

脑血管造影术在现代神经血管医学中发挥核心作用，因为它能够直接观察颅内和颅外血管结构，从而进行诊断和治疗性介入。儘管成像技术不断进步，但脑血管造影在包括急性中风治疗、动脉瘤检测和治疗方案製定、血管畸形评估以及复杂介入神经放射学手术在内的多种临床应用中仍然至关重要。诊断清晰度和操作便利性之间的平衡是临床决策的基础，并推动对设备设计和影像软体的持续投入。

快速的技术进步、流程优化和不断发展的诊疗路径如何重塑脑血管造影术的实践和采购趋势

脑血管造影术领域正经历一场变革，其驱动力来自于技术进步、手术通讯协定的改进以及医疗体系的重组。数位影像处理和即时处理技术的进步使得低剂量、高解析度血管造影术成为可能，从而显着提升了手术安全性和医生的操作水平。与硬体创新同步，软体的进步——尤其是自动化、血管分割和三维重建技术——正在提高手术效率，并支援在复杂介入手术中实现更精准的导航。

评估2025年美国关税对脑血管造影术供应链、采购行为和临床连续性的系统性影响

美国在2025年推出和调整的关税将对脑血管血管造影术生态系统产生累积影响，其影响远不止于即时的成本增加。关税压力将推高进口成像组件、检测器、精密导管及相关耗材的到岸成本，迫使采购团队重新评估其供应商组合。为此，一些製造商将探索本地生产、对国内供应商进行资格认证，或重新设计其供应链以减少对关税敏感领域的依赖。这些调整需要时间和投资，但最终可能增强其抵御贸易政策波动的能力。

设备类型、运作模式、临床应用和最终用户环境的不同策略需求会影响技术采纳和采购决策。

该分析重点阐述了技术应用、营运需求和最终用户优先顺序的关键差异。依设备类型划分，市场分为固定式和移动式。固定式系统通常安装在专用血管造影术室，优先考虑持续高吞吐量、先进的软体模组以及与外科和加护治疗团队的整合。而移动式设备则优先考虑便携性、在混合手术室的快速部署以及跨多个手术区域的灵活排班。依运作模式划分，市场分为类比式和数位式。虽然类比平台仍在一些传统环境中运作，但由于数位系统具有卓越的影像处理、剂量管理以及与电子健康记录的无缝集成，因此在新投资中占据主导地位。按应用划分，市场分为诊断和治疗性介入场景。诊断应用场景优先考虑用于病灶表征的影像清晰度和工作流程效率，而治疗性介入应用场景则需要强大的设备相容性、先进的导航工具和即时影像处理能力来支援治疗操作。依最终用户划分，市场分为门诊手术中心和医院。医院又进一步细分为私立医院和公立医院。日间手术中心正在扩大特定手术的门诊介入项目，私立医院经常投资先进技术来支持重症患者网络，而公立医院则在有限的资本预算和广泛的就医途径之间寻求平衡，优先考虑耐用、可维护的系统来支持大量的患者。

不同地区医疗模式和基础设施的差异会影响采购重点、临床应用和供应商策略。

区域趋势影响着三大关键区域的采购重点、法规环境和临床应用模式。在美洲，医疗系统日益重视整合网路和快速中风通报管道，促使医疗系统投资建造高通量血管造影术室，并加强急诊医学、神经内科和介入治疗团队之间的协作。报销机制和资本规划实践鼓励将高级服务集中在指定的专科中心，而门诊则面临越来越多的低复杂度介入治疗病例。

供应商的关键竞争重点包括模组化硬体、透过软体简化临床工作流程、强调卓越的服务品质以及深化与医疗服务提供者的伙伴关係。

脑血管血管造影术设备领域的竞争主要集中在影像硬体创新、软体主导的工作流程优化以及能够降低供应商整体拥有成本的综合服务模式。主要企业越来越重视模组化系统结构，这种架构允许检测器和处理单元逐步升级，从而延长设备使用寿命，减少系统整体更换的需求。同时，从自动血管分割到手术规划和整合报告等软体功能正成为影响采购决策和长期供应商合作关係的关键差异化因素。

产业相关人员可以采取切实有效、影响深远的策略措施，以加强供应链韧性、加速数位化能力建构并提升临床伙伴关係。

行业领导者可以采取果断措施来维持临床相关性和营运韧性。首先，他们应优先考虑供应链多元化和关键零件的双重采购，以降低贸易政策变化和单一故障点带来的风险。投资于区域製造伙伴关係和灵活的物流可以缩短前置作业时间并提高服务的可预测性。其次，他们应透过整合先进的影像处理、剂量优化和互通性标准，并促进无缝的电子健康记录连接和手术报告，加快整个影像平台的数位转型。

严谨的混合调查方法结合了文献综述、法规审查、专家访谈和比较工具分析，确保了研究结果的可靠性和可操作性。

本研究综合了同侪审查临床文献、监管申报文件、医疗设备技术规范和已发布政策文件的系统性回顾证据，并辅以对介入神经放射学、放射科主任、医疗设备工程师和采购负责人的结构化访谈。资料收集优先考虑目前的操作指南、装置安全建议以及影像引导介入的同侪审查分析，以确保临床准确性和相关性。受访者的选择旨在代表门诊手术中心和医院环境中各类最终用户，从而能够对操作挑战和推广驱动因素进行三角验证。

本文简要概述了技术进步、供应弹性和细分驱动策略如何汇聚起来，以维持和发展脑血管造影术。

脑血管血管造影术兼具诊断准确性与治疗能力，是现代神经血管医学的基石。数位影像、软体驱动的工作流程以及导管设计的进步，使得手术更加安全高效，并拓展了血管造影术的临床应用范围。然而，贸易政策的波动和区域基础设施的差异等外部压力，凸显了建构适应性强的供应链和服务模式的必要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到脑血管造影术中，用于自动血管分割和异常检测
  • 微创微导管技术在复杂颅内动脉瘤治疗的应用日益广泛
  • 我们正在扩建混合血管造影术设备，将锥状射束CT和数位减影血管造影术结合，以进行全面的神经血管评估。
  • 透过实施辐射剂量降低通讯协定和即时影像软体，提高脑血管造影术中的病患安全性。
  • 造影增强 4D 流成像技术越来越受到青睐，用于评估脑血管疾病的血流动力学模式。
  • 在急诊中风照护环境中，对携带式照护现场血管造影术系统的需求日益增长。
  • 开发具有改进黏度特性的生物相容性造影剂，以减少介入神经放射学手术期间的不良反应

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依装置类型分類的脑血管造影术市场

  • 固定类型
  • 移动的

9. 依操作模式分類的脑血管造影术市场

  • 模拟
  • 数位的

第十章 依应用分類的脑血管造影术市场

  • 诊断
  • 介入治疗

第十一章 以最终用户分類的脑血管造影术市场

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院

第十二章：脑血管造影术市场区域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 脑血管造影术市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国脑血管造影术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Bracco Imaging SpA
    • Bayer AG
    • Guerbet SA
    • Terumo Corporation
    • Medtronic plc
    • Stryker Corporation
Product Code: MRR-8E22B619330B

The Cerebral Angiography Market is projected to grow by USD 2.61 billion at a CAGR of 7.05% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.51 billion
Estimated Year [2025] USD 1.62 billion
Forecast Year [2032] USD 2.61 billion
CAGR (%) 7.05%

An authoritative orientation to cerebral angiography objectives, clinical importance, and the convergence of imaging and interventional care in modern neurovascular practice

Cerebral angiography occupies a central role in modern neurovascular medicine by enabling direct visualization of intracranial and extracranial vasculature for both diagnosis and intervention. As imaging modalities evolve, the procedure maintains clinical relevance across acute stroke management, aneurysm detection and treatment planning, vascular malformation assessment, and complex neurointerventional procedures. The interplay between diagnostic clarity and procedural access underpins clinical decision-making and continues to drive investments in both device design and imaging software.

Clinicians value cerebral angiography for its spatial and temporal resolution and for the therapeutic window it provides when interventional approaches are indicated. Innovations in catheter technology, contrast media protocols, x-ray detector sensitivity, and digital image processing have collectively improved procedural safety and efficacy. Consequently, hospital systems and ambulatory surgical centers are recalibrating care pathways to integrate angiographic capabilities into stroke hubs and tertiary neurovascular centers, thereby enabling faster triage and more precise therapeutic delivery.

How rapid technological advances, procedural optimization, and evolving care pathways are reshaping cerebral angiography practice and procurement dynamics

The cerebral angiography landscape is in the midst of transformative shifts driven by technological progress, procedural protocol refinement, and health system-level reconfiguration. Advances in digital imaging and real-time processing now enable higher-resolution angiographic runs with lower radiation dose, which has immediate implications for procedural safety and operator practice. Parallel to hardware innovation, software enhancements-particularly in automation, vessel segmentation, and three-dimensional reconstructions-are increasing procedural efficiency and supporting more accurate navigation during complex interventions.

Beyond technology, clinical pathways have adjusted in response to the pressing need for faster reperfusion in ischemic stroke, leading to more integrated triage systems and streamlined transfer protocols between facilities. These operational changes increase demand for nimble angiography solutions that can be deployed across a range of settings while maintaining high-quality imaging. At the same time, regulatory emphasis on patient safety and device interoperability is prompting manufacturers to prioritize modular, upgradable architectures and to pursue certifications that facilitate cross-platform compatibility. Collectively, these shifts are reshaping investment priorities among providers and influencing procurement strategies across the care continuum.

Assessing the systemic consequences of United States tariff measures in 2025 on cerebral angiography supply chains, procurement behavior, and clinical continuity

The introduction and adjustment of tariffs by the United States in 2025 exert cumulative effects on the cerebral angiography ecosystem that extend beyond immediate cost implications. Tariff pressures raise the landed cost of imported imaging components, detectors, precision-engineered catheters, and ancillary disposables, which prompts procurement teams to reassess supplier portfolios. In turn, some manufacturers respond by seeking localized production, qualifying domestic suppliers, or redesigning supply chains to reduce exposure to tariff-sensitive nodes. These adaptations take time and investment but can ultimately increase resilience to trade policy volatility.

Operationally, facilities face extended lead times and potential substitution of components when preferred parts become subject to higher import duties. Clinicians and biomedical engineering teams must weigh the tradeoffs between short-term availability and long-term performance when selecting alternatives. Meanwhile, policy responses from trading partners and shifts in bilateral trade agreements can influence the flow of medical devices and components, adding another layer of uncertainty. In response, leading suppliers are accelerating dual-sourcing strategies and expanding regional distribution footprints to mitigate the cumulative effects of tariffs on clinical continuity and device support.

Differentiated strategic imperatives driven by equipment type, operation mode, clinical application, and end-user settings shaping technology adoption and procurement decisions

Segmentation-driven insight highlights meaningful differences in technology adoption, operational requirements, and end-user priorities. Based on Equipment Type, market is studied across Fixed and Mobile; Fixed systems, typically installed in dedicated angiography suites, emphasize sustained high throughput, advanced software modules, and integration with surgical and critical care teams, whereas Mobile units prioritize portability, rapid deployment within hybrid operating rooms, and flexible scheduling across multiple procedural areas. Based on Operation Mode, market is studied across Analog and Digital; analog platforms remain in service in some legacy environments but digital systems dominate new investments due to superior image processing, dose management, and seamless integration with electronic health records. Based on Application, market is studied across Diagnostic and Interventional; diagnostic use cases prioritize image clarity and workflow efficiency for lesion characterization, while interventional applications demand robust device compatibility, advanced navigation tools, and real-time imaging capabilities to support therapeutic maneuvers. Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals. The Hospitals is further studied across Private Hospitals and Public Hospitals; ambulatory surgical centers increasingly pursue outpatient interventional programs for selected procedures, private hospitals often invest in premium technology to support high-acuity referral networks, and public hospitals balance broad access with constrained capital planning, prioritizing durable, serviceable systems that support high patient volumes.

These segmentation perspectives reveal that procurement criteria differ across settings: fixed, high-volume suites favor system longevity and advanced imaging suites, while mobile and ambulatory contexts value compact footprint and rapid setup. Similarly, digitalization and interventional use cases accelerate demand for software-enabled workflows and vendor-supported training. Understanding these segmentation-based distinctions enables suppliers and providers to align product development, service models, and clinical training to the nuanced needs of each end-user type.

How distinct regional healthcare models and infrastructure variations across key geographies influence procurement priorities, clinical adoption, and supplier strategies

Regional dynamics influence procurement priorities, regulatory environments, and clinical utilization patterns across three broad geographies. In the Americas, health systems often focus on integrated networks and rapid stroke referral pathways, which incentivize investment in high-throughput angiography suites and close coordination between emergency medicine, neurology, and interventional teams. Reimbursement structures and capital planning practices encourage consolidation of advanced services in designated centers of excellence while ambulatory settings expand case portfolios for lower-complexity interventions.

In Europe, Middle East & Africa, the landscape presents heterogeneity driven by varied regulatory regimes, public versus private funding models, and infrastructure disparities. Many urban tertiary centers in this region pursue cutting-edge imaging upgrades and interventional program expansion, while regions with constrained resources prioritize durable platforms and remote support capabilities. In the Asia-Pacific region, rapid adoption of digital imaging, increasing investment in tertiary neurovascular programs, and a growing emphasis on domestic manufacturing and regulatory harmonization are notable trends. Across regions, suppliers adapt distribution and support strategies to meet differing clinical protocols, regulatory timelines, and capital procurement cycles, thereby shaping how technologies diffuse into practice.

Key competitive priorities for vendors emphasizing modular hardware, software-enabled clinical workflows, and service excellence to deepen provider partnerships

Competitive dynamics among companies servicing the cerebral angiography domain center on innovation in imaging hardware, software-driven workflow enhancements, and comprehensive service models that reduce total cost of ownership for providers. Leading firms increasingly prioritize modular system architectures that allow iterative upgrades to detectors and processing units, which supports longer equipment lifecycles and mitigates the need for full-system replacements. At the same time, software capabilities-ranging from automated vessel segmentation to procedural planning and integrated reporting-have become differentiating features that influence purchasing decisions and long-term vendor relationships.

Strategic partnerships between device manufacturers, software developers, and clinical centers are accelerating the translation of research into practice, enabling early validation of novel image-guided techniques. Service offerings that combine preventive maintenance, remote diagnostics, and expedited parts logistics are also central to company positioning, particularly for customers balancing procedural volume with constrained capital budgets. Overall, firms that demonstrate interoperability, robust clinical evidence, and responsive service networks tend to secure deeper integration within provider ecosystems and maintain stronger post-sale engagement.

Practical, high-impact strategic moves that industry stakeholders can implement to enhance supply resilience, accelerate digital capabilities, and strengthen clinical partnerships

Industry leaders can take decisive steps to sustain clinical relevance and operational resilience. First, prioritize supply chain diversification and dual-sourcing for critical components to reduce exposure to trade policy shifts and single points of failure. Investing in regional manufacturing partnerships and flexible logistics arrangements will shorten lead times and improve service predictability. Second, accelerate digital transformation across imaging platforms by integrating advanced image processing, dose optimization, and interoperability standards that facilitate seamless electronic health record connectivity and procedural reporting.

Third, align product development with evolving clinical workflows by supporting both diagnostic clarity and interventional utility; systems that bridge these needs will better serve integrated stroke and neurovascular programs. Fourth, strengthen post-sale relationships through outcome-focused service offerings, including remote monitoring, predictive maintenance, and clinician training programs that shorten learning curves for advanced procedures. Finally, engage proactively with health policy stakeholders to clarify regulatory pathways and to design reimbursement strategies that reflect the value of image-guided intervention, thereby enabling more sustainable adoption across diverse healthcare settings.

A rigorous, mixed-methods research approach combining literature, regulatory review, expert interviews, and comparative device analysis to ensure robust and actionable insights

This research synthesizes evidence from a systematic review of peer-reviewed clinical literature, regulatory filings, device technical specifications, and publicly available policy documents, supplemented by structured interviews with practicing neurointerventionalists, radiology department leaders, biomedical engineers, and procurement professionals. Data collection prioritized recent procedural guidelines, device safety advisories, and peer-reviewed analyses of image-guided interventions to ensure clinical accuracy and relevance. Interview subjects were selected to represent a cross-section of end users across ambulatory surgical centers and hospital settings, enabling triangulation of operational challenges and adoption drivers.

Analytic methods combined qualitative thematic analysis of interview data with comparative evaluation of device features and post-market surveillance reports. Segmentation frameworks were applied to evaluate how equipment type, operation mode, application, and end-user setting influence procurement criteria and clinical workflows. Throughout the research process, findings underwent independent expert validation to ensure robustness, and limitations related to data availability and regional heterogeneity were explicitly documented to guide interpretation and application of the insights.

A concise synthesis of how technological progress, supply resilience, and segmentation-aligned strategies converge to sustain and advance cerebral angiography practice

Cerebral angiography remains a cornerstone of modern neurovascular care, positioned at the intersection of diagnostic precision and therapeutic capability. Technological advancements in digital imaging, software-enabled workflows, and catheter design are enabling safer, more efficient procedures while simultaneously expanding the clinical settings in which angiography can be deployed. However, external pressures such as trade policy shifts and regional infrastructure variability underscore the need for adaptable supply chains and service models.

Providers and suppliers that adopt a segmentation-aware approach-recognizing distinct requirements for fixed versus mobile systems, analog versus digital operation modes, diagnostic versus interventional applications, and differences among ambulatory centers and hospital types-will be best positioned to align investments with clinical and operational priorities. In short, the path forward demands coordinated action across technology innovation, supply chain resilience, and clinician-centered service delivery to ensure that angiographic capabilities continue to advance patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated vessel segmentation and anomaly detection in cerebral angiography
  • 5.2. Rising utilization of minimally invasive microcatheter technologies for complex intracranial aneurysm interventions
  • 5.3. Expansion of hybrid angiography suites combining cone beam CT and digital subtraction angiography for comprehensive neurovascular assessment
  • 5.4. Adoption of radiation dose reduction protocols and real-time imaging software to enhance patient safety in cerebral angiography
  • 5.5. Increasing preference for contrast-enhanced 4D flow imaging techniques to evaluate hemodynamic patterns in cerebrovascular disorders
  • 5.6. Growth in demand for portable and point-of-care angiography systems in emergency stroke intervention settings
  • 5.7. Development of biocompatible contrast agents with improved viscosity profiles to reduce adverse reactions during neurointerventional procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cerebral Angiography Market, by Equipment Type

  • 8.1. Fixed
  • 8.2. Mobile

9. Cerebral Angiography Market, by Operation Mode

  • 9.1. Analog
  • 9.2. Digital

10. Cerebral Angiography Market, by Application

  • 10.1. Diagnostic
  • 10.2. Interventional

11. Cerebral Angiography Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals

12. Cerebral Angiography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cerebral Angiography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cerebral Angiography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Siemens Healthineers AG
    • 15.3.2. GE HealthCare Technologies Inc.
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Bracco Imaging S.p.A.
    • 15.3.6. Bayer AG
    • 15.3.7. Guerbet S.A.
    • 15.3.8. Terumo Corporation
    • 15.3.9. Medtronic plc
    • 15.3.10. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CEREBRAL ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 79. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 83. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 85. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 94. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 106. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 148. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 180. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 186. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 187. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 192. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 193. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 198. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 216. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 217. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 228. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 229. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 234. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 235. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 240. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 241. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 259. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 262. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 263. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 272. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 273. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 278. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 279. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 283. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 299. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 303. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 308. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 309. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 313. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 318. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 319. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 322. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 323. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 332. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 333. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 338. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 339. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 342. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 343. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLIO